| P2093 | author name string | Qing Sun | |
| | Chun-Yang Li | |
| | Chun-Lei Zhou | |
| | Da-Xing Cai | |
| | Xiao-Jing Yu | |
| | Yong-Hao Xu | |
| P2860 | cites work | Serum levels of interleukin-18 and s-ICAM-1 in patients affected by psoriasis: preliminary considerations | Q73041109 |
| | Pleiotropic effects of corticotropin releasing hormone on normal human skin keratinocytes | Q73616079 |
| | Expression of IL-18 in psoriasis | Q74497138 |
| | Extracellular regulated kinase and c-Jun N-terminal kinase are activated in psoriatic involved epidermis | Q78467527 |
| | Corticotropin-releasing hormone induces proliferation and TNF-alpha release in cultured rat microglia via MAP kinase signalling pathways | Q78672797 |
| | Skin corticotropin-releasing hormone receptor expression in psoriasis | Q79849792 |
| | Expression and localization of the activated mitogen-activated protein kinase in lesional psoriatic skin | Q80544906 |
| | The mitogen-activated protein kinases p38 and ERK1/2 are increased in lesional psoriatic skin | Q81288767 |
| | Plasma and scales levels of interleukin 18 in comparison with other possible clinical and laboratory biomarkers of psoriasis activity | Q83966456 |
| | The role of neuropeptides in psoriasis | Q28267941 |
| | Corticotropin-releasing hormone induces Fas ligand production and apoptosis in PC12 cells via activation of p38 mitogen-activated protein kinase | Q28582709 |
| | Mitogen-activated protein kinase pathways | Q29618431 |
| | Mitogen-activated protein kinases: specific messages from ubiquitous messengers | Q30303652 |
| | In situ expression of corticotropin-releasing hormone (CRH) and proopiomelanocortin (POMC) genes in human skin | Q30700489 |
| | Interleukin-18. | Q30884172 |
| | Human keratinocytes constitutively produce but do not process interleukin-18. | Q33914634 |
| | Differential expression of a cutaneous corticotropin-releasing hormone system | Q33947567 |
| | Corticotropin releasing hormone and proopiomelanocortin involvement in the cutaneous response to stress | Q33967651 |
| | Tumor necrosis factor signaling. | Q34185821 |
| | Serum levels of TNF-alpha, IFN-gamma, IL-6, IL-8, IL-12, IL-17, and IL-18 in patients with active psoriasis and correlation with disease severity | Q34945351 |
| | MAP kinase modules: many roads home. | Q35582557 |
| | Psychiatric and psychological co-morbidity in patients with dermatologic disorders: epidemiology and management | Q35593911 |
| | Corticotropin releasing hormone and the skin | Q35740745 |
| | Getting under the skin: the immunogenetics of psoriasis | Q36247085 |
| | Neuroendocrine system of the skin | Q36276700 |
| | The role of corticotropin-releasing hormone in immune-mediated cutaneous inflammatory disease | Q36397314 |
| | Innate and adaptive immunity and the pathophysiology of psoriasis | Q36400854 |
| | Expression of the corticotropin-releasing hormone-proopiomelanocortin axis in the various clinical types of psoriasis | Q36707561 |
| | Interleukin-18 and stress | Q37092791 |
| | Molecular and functional characterization of novel CRFR1 isoforms from the skin | Q38339907 |
| | Corticotropin-releasing hormone attenuates vascular endothelial growth factor release from human HaCaT keratinocytes | Q39784089 |
| | CRH functions as a growth factor/cytokine in the skin | Q40358647 |
| | Corticotropin-releasing hormone (CRH) downregulates interleukin-18 expression in human HaCaT keratinocytes by activation of p38 mitogen-activated protein kinase (MAPK) pathway | Q40437601 |
| | Corticotropin-releasing hormone affects cytokine production in human HaCaT keratinocytes | Q40748890 |
| | Human keratinocytes are major producers of IL-18: predominant expression of the unprocessed form | Q40850786 |
| | CRH and the immune system | Q41355419 |
| | Up-regulation of keratin 17 expression in human HaCaT keratinocytes by interferon-gamma | Q41405310 |
| | A keratinocyte cell line synthesizes a predominant insulin-like growth factor-binding protein (IGFBP-3) that modulates insulin-like growth factor-I action | Q41434384 |
| | Antiproliferative potential of zidovudine in human keratinocyte cultures | Q41666215 |
| | On the role of the corticotropin-releasing hormone signalling system in the aetiology of inflammatory skin disorders | Q43171063 |
| | Corticotropin-releasing hormone induces keratinocyte differentiation in the adult human epidermis | Q45093064 |
| | Involvement of the corticotropin-releasing hormone system in the pathogenesis of acne vulgaris | Q46200995 |
| | Corticotropin-releasing hormone contributes to the peripheral inflammatory response in experimental autoimmune encephalomyelitis | Q46448124 |
| | Interleukin-18 levels in the plasma of psoriatic patients correlate with the extent of skin lesions and the PASI score. | Q52006091 |
| | The human skin as a hormone target and an endocrine gland. | Q52930459 |
| | Comparison of expression of heat-shock protein 60, Toll-like receptors 2 and 4, and T-cell receptor gammadelta in plaque and guttate psoriasis. | Q53557801 |
| P433 | issue | 3 | |
| P304 | page(s) | 1003-1011 | |
| P577 | publication date | 2015-06-01 | |
| P1433 | published in | Inflammation | Q2560341 |
| P1476 | title | Inhibiting interleukin-18 production through the mitogen-activated protein kinase pathway, a potential role of corticotropin-releasing hormone in chronic plaque psoriasis | |
| P478 | volume | 38 | |